Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Covid19- Coronavirus- Sars-cov-2”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableUnknownNCT05543408
What this trial is testing

Long COVID-19 Syndrome in Primary Care: A Novel Protocol of Exercise Intervention "CON-VIDA Clinical Trial"

Who this might be right for
COVID-19Long COVIDPost-COVID-19 Syndrome
Universidad San Jorge 40
Testing effectiveness (Phase 2)Study completedNCT05605470
What this trial is testing

Immunogenicity and Safety of ChulaCov19 BNA159 and ChulaCov19 BNA159.2 Vaccines as a Booster Dose in Adults

Who this might be right for
COVID-19, SARS CoV 2 Infection
Technovalia, Pty Ltd 150
Large-scale testing (Phase 3)UnknownNCT06068569
What this trial is testing

Study of the Vector Vaccine GamCovidVac for the Prevention of COVID-19 With Altered Antigenic Profile With Participation of Adult Volunteers

Who this might be right for
COVID-19
Gamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian Federation 50
Testing effectiveness (Phase 2)Study completedNCT04671017
What this trial is testing

Dose Finding Study to Evaluate The Safety, Tolerability and Immunogenicity of an Inactiviated, Adjuvanted SARS-CoV-2 Virus Vaccine Candidate Against Covid-19 in Healthy Subjects

Who this might be right for
SARS-CoV-2 Virus Infection
Valneva Austria GmbH 153
Not applicableUnknownNCT05125874
What this trial is testing

Clinical Study for Recombinant SARS-CoV-2 Fusion Protein Vaccine (V-01) Booster Immunization

Who this might be right for
COVID-19 Pandemic
Livzon Pharmaceutical Group Inc. 45
Not applicableStudy completedNCT04753762
What this trial is testing

Multimodal IMAgery Characterization of Cardiac Damage and Severity After COVID-19 Infection

Who this might be right for
COVID-19 Virus DiseaseCardiac Complication
Central Hospital, Nancy, France 50
Not applicableStudy completedNCT04380727
What this trial is testing

Almitrine and COVID-19 Related Hypoxemia

Who this might be right for
COVID-19Hypoxic Respiratory Failure
Central Hospital, Nancy, France 17
Not applicableUnknownNCT04449627
What this trial is testing

Psychological Impact of Admission With Covid-19 During the SARS-CoV-2 Pandemic: Naturalistic Cohort Study With a Digital Intervention

Who this might be right for
Anxiety DisordersPost Traumatic Stress DisorderDepressive Disorder+1 more
Royal Free Hospital NHS Foundation Trust 125
Very early researchUnknownNCT04530370
What this trial is testing

Efficacy and Safety of Recovered Covid 19 Plasma Transfusion to Covid 19 Severly Ill Patients

Who this might be right for
Covid19
South Valley University 30
Testing effectiveness (Phase 2)Study completedNCT04608305
What this trial is testing

Evaluate the Safety, Immunogenicity and Potential Efficacy of an rVSV-SARS-CoV-2-S Vaccine

Who this might be right for
Covid19
Israel Institute for Biological Research (IIBR) 843
Not applicableUnknownNCT05855356
What this trial is testing

Post Covid-19 Dysautonomia Rehabilitation Randomized Controlled Trial

Who this might be right for
Post-Acute COVID-19 SyndromeDysautonomia
Evangelismos Hospital 50
Not applicableStudy completedNCT04673279
What this trial is testing

Long-term COVID-19 Immune Response in a Vulnerable Neighbourhood in Argentina

Who this might be right for
Coronavirus Disease 2019
Hospital Italiano de Buenos Aires 189
Large-scale testing (Phase 3)Temporarily pausedNCT04341870
What this trial is testing

Study of Immune Modulatory Drugs and Other Treatments in COVID-19 Patients: Sarilumab, Azithromycin, Hydroxychloroquine Trial - CORIMUNO-19 - VIRO

Who this might be right for
COVID19SARS-CoV-2 Infection
Assistance Publique - Hôpitaux de Paris 27
Not applicableStudy completedNCT06191341
What this trial is testing

Consequences in ICU of Vaccination Status of Covid-19 Patients

Who this might be right for
SARS CoV 2 Infection
Centre Hospitalier Régional Metz-Thionville 1,058
Not applicableUnknownNCT04423640
What this trial is testing

Analysis of the Inflammatory Response and the Development of Humoral and Cellular Immunity in Patients With COVID-19

Who this might be right for
SARS-CoV-2
Coordinación de Investigación en Salud, Mexico 200
Testing effectiveness (Phase 2)Looking for participantsNCT06684379
What this trial is testing

Study on Safety and Efficacy of Two Doses of PRS CK STORM in the Modulation of the Cytokine Storm in Patients With Acute Respiratory Infection Caused by SARS-Cov-2, Influenza A, Influenza B and Respiratory Syncytial Virus (RSV)

Who this might be right for
SARS-CoV-2Influenza, HumanRespiratory Syncytial Virus Infections+2 more
PEACHES BIOTECH 50
Not applicableWithdrawnNCT04351490
What this trial is testing

Impact of Zinc and Vitamin D3 Supplementation on the Survival of Aged Patients Infected With COVID-19

Who this might be right for
SARS-CoV 2
University Hospital, Lille
Not applicableLooking for participantsNCT05638724
What this trial is testing

Munich Long COVID Registry for Children, Adolescents, and Adults

Who this might be right for
Post-COVID Condition
Technical University of Munich 1,000
Not applicableStudy completedNCT04667923
What this trial is testing

Noninvasive Ventilation in Moderate-to-severe COVID-19-associated Acute Respiratory Distress-syndrome

Who this might be right for
Covid19ARDS
I.M. Sechenov First Moscow State Medical University 80
Large-scale testing (Phase 3)Study completedNCT04655625
What this trial is testing

Phase II / III Study of COVID-19 DNA Vaccine (AG0302-COVID19)

Who this might be right for
COVID-19
AnGes, Inc. 500
Next Page